Congress funds alternative protein research as national security priority
S. 3528 — Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act · Filed by Adam Schiff (D-CA) · 3 cosponsors · Introduced Dec 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the U.S. Department of Agriculture to establish research centers and grant programs focused on developing alternative protein sources through bioprocessing and biomanufacturing—using underutilized crops and biomass to create food proteins and fats. It authorizes $100 million over five years for research centers, workforce training, commercial-scale production facilities, and a national strategy coordinating multiple federal agencies. The bill aims to diversify the U.S. protein supply, create jobs, strengthen food security, and position America as a global leader in food innovation.
Why we flagged it
The bill's core mechanism is public investment in research, production infrastructure, and workforce training for alternative protein technology. It is a strategic industrial policy aimed at food security and economic competitiveness, not a tax break, subsidy to a named entity, or deregulation.
What the text implies
- The bill's emphasis on 'bioprocessing' and 'biomanufacturing' of plant-based and fermentation-derived proteins may accelerate market displacement of conventional livestock agriculture, affecting rural farmers dependent on cattle, poultry, and dairy—though the bill includes language about 'farmer profits' and rural prosperity, implementation details are unclear.
- The grant program's $10M minimum per award and $50M annual authorization may concentrate funding among large institutions and well-capitalized firms, potentially limiting access for smaller startups or rural cooperatives despite workforce-development language.
- The national strategy's involvement of Defense, Energy, Commerce, NSF, NIH, FDA, CDC, EPA, and OSTP signals framing of protein innovation as a national-security issue, which may justify accelerated regulatory pathways or classified research components not visible in this bill.
- The rule of construction explicitly excluding insects from the bill's scope suggests prior legislative or stakeholder pressure on this topic; the exclusion may signal future conflict over insect-protein regulation.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds public research and workforce development in an emerging sector with broad public benefits: food security, supply-chain resilience, job creation, and consumer choice. While private companies and universities are eligible grantees, the funding is directed toward a public good (protein diversification) with explicit workforce-development and rural-prosperity components, not a narrow private carve-out.
Who stands to gain
- universities and research institutions (research grants)
- for-profit food biomanufacturing companies (production grants, minimum $10M per award)
- nonprofit organizations (eligible for grants)
- agricultural biotechnology sector
- workforce training providers and community colleges
Named in the bill
U.S. Department of Agriculture (USDA), Secretary of Agriculture, 1890 Institutions (historically Black colleges and universities), National Laboratories, Agricultural Research Service, Secretary of Defense, Secretary of Energy, Secretary of Commerce, National Science Foundation, National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention — and 2 more
Where it stands
3 cosponsors: 3 Democrats.
- Dec 17, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Dec 17, 2025 — Referred to Senate Committee on Agriculture, Nutrition, and Forestry · Congress.gov: “Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $180,000 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Adam Schiff, the sponsor, reported $54,400 in PAC receipts in the 2026 cycle.
- Food Solutions Action — $180,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (11,952 characters) on Jun 3, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress funds alternative protein research as national security priority” QuorumCivic. https://share.quorumcivic.app/bill/119/s3528 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.